Millennium Management
NXTC icon

Millennium Management’s NextCure NXTC Stock Holding History

Millennium Management’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,033
Closed -$185K – 6172
2025
Q4 		$185K Buy
+13,033
New +$135K ﹤0.01% 5491
2025
Q2 		– Sell
-1,023
Closed -$5.89K – 6196
2025
Q1 		$5.89K Sell
1,023
-2,520
-71% -$22.2K ﹤0.01% 5708
2024
Q4 		$32.8K Sell
3,543
-2,467
-41% -$36.3K ﹤0.01% 5654
2024
Q3 		$98.8K Sell
6,010
-32,185
-84% -$592K ﹤0.01% 5590
2024
Q2 		$729K Sell
38,195
-56,312
-60% -$1.1M ﹤0.01% 4341
2024
Q1 		$2.53M Sell
94,507
-525
-0.6% -$9.04K ﹤0.01% 3516
2023
Q4 		$1.3M Sell
95,032
-23,514
-20% -$341K ﹤0.01% 3950
2023
Q3 		$1.84M Buy
118,546
+1,125
+1% +$21.5K ﹤0.01% 3635
2023
Q2 		$2.54M Sell
117,421
-3,747
-3% -$73.8K ﹤0.01% 3268
2023
Q1 		$2.15M Buy
121,168
+9,752
+9% +$188K ﹤0.01% 3375
2022
Q4 		$1.89M Buy
111,416
+10,124
+10% +$233K ﹤0.01% 3623
2022
Q3 		$3.34M Buy
101,292
+8,426
+9% +$429K ﹤0.01% 3274
2022
Q2 		$5.24M Buy
92,866
+8,424
+10% +$440K ﹤0.01% 2760
2022
Q1 		$4.92M Buy
84,442
+443
+0.5% +$27.7K ﹤0.01% 2956
2021
Q4 		$6.05M Buy
83,999
+35,155
+72% +$2.94M ﹤0.01% 2707
2021
Q3 		$3.95M Buy
48,844
+15,234
+45% +$1.34M ﹤0.01% 3141
2021
Q2 		$3.24M Buy
33,610
+26,102
+348% +$2.67M ﹤0.01% 3338
2021
Q1 		$902K Buy
7,508
+196
+3% +$28.4K ﹤0.01% 4320
2020
Q4 		$956K Sell
7,312
-33,909
-82% -$4.38M ﹤0.01% 3772
2020
Q3 		$4.35K Buy
41,221
+29,997
+267% +$3.69M 0.01% 1969
2020
Q2 		$2.89M Buy
11,224
+5,914
+111% +$2.25M ﹤0.01% 2252
2020
Q1 		$2.36M Buy
5,310
+939
+21% +$501K 0.01% 1895
2019
Q4 		$2.96M Buy
+4,371
New +$2.19M ﹤0.01% 2349
2019
Q3 		– Sell
-2,511
Closed -$451K – 4444
2019
Q2 		$451K Buy
+2,511
New +$522K ﹤0.01% 3303

Other funds holding NXTC

SCM
Squadron Capital Management Westmont, Illinois $273M AUM
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
EAM
Exome Asset Management New York $193M AUM 208.51% 1-Year Est. Return

Millennium Management's NXTC Position: Q1 2026 in Review

Millennium Management sold out of NextCure (NXTC) in Q1 2026, closing a stake of 13,033 shares — an estimated $185K sold.

Millennium Management first reported a position in NXTC in Q2 2019 and held it in 24 quarters. The position peaked at $6.05M in Q4 2021. 26 funds tracked by Wall St. Rank hold NXTC as of Q1 2026.

  • Millennium Management reported no remaining NextCure position as of Q1 2026 after selling out during the quarter.
  • Millennium Management sold 13,033 NextCure shares in Q1 2026, an estimated $185K.
  • Millennium Management first reported a position in NextCure in Q2 2019 and held it in 24 quarters.
  • Millennium Management's NextCure position peaked at $6.05M in Q4 2021.
  • 26 funds tracked by Wall St. Rank held NextCure as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.